3954
J. J. Song et al. / Tetrahedron Letters 50 (2009) 3952–3954
3.1.5. 6-Adamantan-1-yl-5H-pyrrolo[3,2-d]pyrimidine (6e)
N
Ph
N
1H NMR (DMSO-d6, 400 MHz) d 11.63 (s, 1H), 8.71 (s, 2H), 6.30
(s, 1H), 2.05 (s, 3H), 1.97 (s, 6H), 1.74 (s, 6H). 13C NMR (DMSO-d6,
100 MHz) d 157.6, 149.8, 138.1, 127.1, 95.5, 41.2, 36.0, 34.0, 27.7.
HPLC: 100 area%. HRMS calcd for the [M+1]+: 254.1651, found:
254.1657.
N
PhCO2Et
Ph
LiO
Li
N
O
N
N
H
-40 o
C
N
HN
Li
HN
Li
5
3
4
N
Ph
N
3.1.6. 1-Naphthalen-2-yl-3-(5H-pyrrolo[3,2-d]pyrimidin-6-yl)-
propan-1-ol (6f)
N
H
6a
Figure 2. Proposed reaction pathway.
1H NMR (DMSO-d6, 400 MHz) d 11.71 (br s, 1H), 8.71 (s, 1H),
8.70 (s, 1H), 8.00–7.85 (m, 4H), 7.57–7.42 (m, 3H), 6.38 (s, 1H),
5.50 (d, J = 4.40 Hz, 1H), 4.78 (ddd, J = 7.20, 5.30, 5.30 Hz, 1H),
2.97–2.82 (m, 2H), 2.22–2.05 (m, 2H). 13C NMR (DMSO-d6,
100 MHz) d 150.3, 149.8, 149.1, 143.3, 137.9, 132.8, 132.2, 127.7,
127.6, 127.5, 127.2, 126.0, 125.5, 124.5, 124.0, 98.4, 71.5, 37.7,
24.6. HPLC: 100 area%. HRMS calcd for the [M+1]+: 304.1444,
found: 304.1454.
isolated products were also measured by HPLC. HPLC method: Tos-
m; wave-
ohass super-ODS column 4.6 mm  5 cm, particle size 2
l
length 220 nm; gradient 10% acetonitrile/water (with 0.05%
trifluoroacetic acid) to 90% in 3.5 min, hold 1.5 min; flow rate
2 mL/min at 25 °C.
Supplementary data
3.1.1. 6-Phenyl-5H-pyrrolo[3,2-d]pyrimidine (6a)
1H NMR (DMSO-d6, 400 MHz) d 12.31 (br s, 1H), 8.87 (s, 1H),
8.81 (s, 1H), 8.00 (d, J = 7.36 Hz, 2H), 7.54 (t, J = 7.32 Hz, 2H), 7.45
(m, 1H), 7.14 (s, 1H). 13C NMR (DMSO-d6, 100 MHz) d 150.5,
150.2, 144.9, 139.3, 130.6, 129.4, 129.1, 128.4, 126.2, 98.3. HPLC:
100 area%. HRMS calcd for the [M+1]+: 196.0869, found: 196.0873.
Supplementary data associated with this article can be found, in
References and notes
1. For recent reviews on indole chemistry, see: (a) Humphrey, G. R.; Kuethe, J. T.
Chem. Rev. 2006, 106, 2875 and references cited therein; (b) Gribble, G. W. J.
Chem. Soc., Perkin Trans. 1 2000, 1045 and references cited therein.
2. For recent reviews on azaindole synthesis, see: (a) Song, J. J.; Reeves, J. T.; Gallou,
F.; Tan, Z.; Yee, N. K.; Senanayake, C. H. Chem. Soc. Rev. 2007, 36, 1120; (b)
Popowycz, F.; Merour, J.-Y.; Joseph, B. Tetrahedron 2007, 63, 8689.
3. Song, J. J.; Tan, Z.; Gallou, F.; Xu, J.; Yee, N. K.; Senanayake, C. H. J. Org. Chem.
2005, 70, 6512.
4. For lateral carbolithiation-based indole and azaindole methods requiring the use
of protecting groups, see: (a) Smith, A. B., III; Visnick, M.; Haseltine, J. N.;
Sprengeler, P. A. Tetrahedron 1986, 42, 2957; (b) Hands, D.; Bishop, B.; Cameron,
M.; Edwards, J. S.; Cottrell, I. F.; Wright, S. H. B. Synthesis 1996, 877.
5. For papers on synthesis of 4,6-diazaindoles, see: (a) Harcken, C.; Ward, Y.;
Thomson, D.; Riether, D. Synlett 2005, 3121; (b) Rodriguez, A. L.; Koradin, C.;
Dohle, W.; Knochel, P. Angew. Chem., Int. Ed. 2000, 39, 2488; (c) Cupps, T. L.;
Wise, D. S.; Townsend, L. B. J. Org. Chem. 1983, 48, 1060; (d) Norman, M. H.;
Chen, N.; Chen, Z.; Fotsch, C.; Hale, C.; Han, N.; Hurt, R.; Jenkins, T.; Kincaid, J.;
Liu, L.; Lu, Y.; Moreno, O.; Santora, V. J.; Sonnenberg, J. D.; Karbon, W. J. Med.
Chem. 2000, 43, 4288.
6. For papers on synthesis of other diazaindole isomers, see: (a) Ames, D. E.; Bull, D.
Tetrahedron 1982, 38, 383; (b) Ames, D. E.; Brohi, M. I. J. Chem. Soc., Perkin Trans.
1 1980, 1384; (c) Vierfond, J. M.; Mettey, Y.; Mascrier-Demagny, L.; Miocque, M.
Tetrahedron Lett. 1981, 22, 1219; (d) Crooks, P. A.; Robinson, B. Can. J. Chem.
1969, 47, 2061; (e) Klutchko, S.; Hansen, H. V.; Meltzer, R. I. J. Org. Chem. 1965,
30, 3454.
7. 5-Amino-4-methylpyrimidine is commercially available in multi-kilogram
quantities from several vendors.
8. For reviews on lateral lithiation reactions, see: (a) Clark, R. D.; Johangir, A. In
Organic Reactions; John Wiley & Sons: New York, 1995; Vol. 47; (b) Snieckus, V.
Chem. Rev. 1990, 90, 879; (c) Beak, P.; Snieckus, V. Acc. Chem. Res. 1982, 15, 306.
3.1.2. 6-(3-Bromophenyl)-5H-pyrrolo[3,2-d]pyrimidine (6b)
1H NMR (DMSO-d6, 400 MHz) d 12.38 (br s, 1H), 8.90 (s, 1H),
8.82 (s, 1H), 8.24 (s, 1H), 8.01 (d, J = 7.80 Hz, 1H), 7.63 (d,
J = 7.96 Hz, 1H), 7.49 (t, J = 7.88 Hz, 1H), 7.24 (s, 1H). 13C NMR
(DMSO-d6, 100 MHz) d 150.6, 149.9, 143.0, 139.7, 132.9, 131.9,
131.2, 128.5, 128.4, 126.2, 125.2, 122.5, 99.4. HPLC: 100 area%.
HRMS calcd for the [M+1]+: 273.9974, found: 273.9989.
3.1.3. 6-Phenethyl-5H-pyrrolo[3,2-d]pyrimidine (6c)
1H NMR (DMSO-d6, 400 MHz) d 11.78 (br s, 1H), 8.74 (s, 1H),
8.70 (s, 1H), 7.27 (m, 4H), 7.18 (m, 1H), 6.36 (s, 1H), 3.12 (m,
2H), 3.05 (m, 2H). 13C NMR (DMSO-d6, 100 MHz) d 150.2, 149.9,
148.4, 140.7, 138.1, 128.3, 128.2, 127.1, 126.0, 98.8, 34.0, 29.7.
HPLC: 98.9 area%. HRMS calcd for the [M+1]+: 224.1182, found:
224.1190.
3.1.4. 6-Propyl-5H-pyrrolo[3,2-d]pyrimidine (6d) (known
compound5a
)
1H NMR (DMSO-d6, 400 MHz) d 11.70 (br s, 1H), 8.72 (s, 1H),
8.71 (s, 1H), 6.35 (d, J = 1.00 Hz, 1H), 2.79 (t, J = 7.52 Hz, 2H), 1.74
(m, 2H), 0.94 (t, J = 7.32 Hz, 3H). 13C NMR (DMSO-d6, 100 MHz) d
150.3, 149.8, 149.1, 146.6, 137.9, 127.2, 98.5, 29.9, 21.6, 13.6. HPLC:
100 area%. HRMS calcd for the [M+1]+: 162.1025, found: 162.1030.